Company / Free Cash Flow per Share
Xeris Biopharma Holdings, Inc. Free Cash Flow per Share History
FY2020-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.27
FY2021
5-year range
-$2.27 / -$2.27
FY2020-FY2021
Trend
-19.4%
vs FY2020
Sector context
#138 of 192
Health Care
What the data says
At $-2.27, Xeris Biopharma Holdings, Inc.'s free cash flow per share ranks #138 of 192 in the Health Care sector.
Based on SEC 10-K filings.
-2.27 in FY2021.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#138 of 192 in Health CareTop 72% of 192This company -$2.27 Sector average -$19.84
▼
+88.6% above sector average
Key checks
Key Insights
- In FY2021, free cash flow per share decreased 19.4% year-over-year.
- Ranks #138 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$2.27 | -19.4% |
| FY2020 | -$1.90 | - |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026